BCK Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

BCK Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,642	Closed	-$718K	–	93
2023 Q4	$718K	Buy	+43,642	New	+$687K	0.7%	46

BCK Capital Management's ORTX Position: Q1 2024 in Review

BCK Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 43,642 shares — an estimated $718K sold.

BCK Capital Management first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $718K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

BCK Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
BCK Capital Management sold 43,642 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $718K.
BCK Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
BCK Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $718K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on BCK Capital Management's 13F filing for Q1 2024, filed 8 May 2024.